Wednesday, December 9, 2015

Nature Biotechnology Contents: Volume 33 pp 1213 - 1300

If you are unable to see the message below, click here to view.
Nature Biotechnology

TABLE OF CONTENTS

December 2015 Volume 33, Issue 12

Editorial
News
Bioentrepreneur
Opinion and Comment
Features
News and Views
Computational Biology
Research
Careers and Recruitment

Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Advertisement

BIOPHARMA DEALMAKERS
BIOPHARMA DEALMAKERSCompany Profiles and Partnering Opportunities


 
Advertisement
Nature Protocols is setting the benchmark for publishing high-quality peer-reviewed protocols for biological and biomedical research, containing all the technical info you need to reproduce experiments in your own lab.

Visit the Nature Protocols website to access our step-by-step guides to using and adapting research techniques from the world's leading laboratories.

www.nature.com/nprot 
 
 

Editorial

Top

20 years of bio-lox   p1213
doi:10.1038/nbt.3438
Here's hoping that a proposed shakeup of US regulations will mean that new biotech products avoid AquaAdvantage salmon's two-decade upstream struggle to regulatory approval.

News

Top

Anti-CD20 antibody wows in multiple sclerosis   pp1215 - 1216
Cormac Sheridan
doi:10.1038/nbt1215-1215

Predictive biomarkers for checkpoints, first tests approved   pp1217 - 1218
Ken Garber
doi:10.1038/nbt1215-1217

IBM debuts hyped 'cognitive cloud' biotech HQ in Cambridge   pp1219 - 1220
Lucas Laursen
doi:10.1038/nbt1215-1219

23andMe protects consumers' data   p1220
Laura DeFrancesco
doi:10.1038/nbt1215-1220

A face-lift for biotech rules begins   pp1221 - 1222
Emily Waltz
doi:10.1038/nbt1215-1221

Tumor macrophage target fuels $1.7-billion deal   p1222
Ken Garber
doi:10.1038/nbt1215-1222

Trade pact blow for innovative drug developers   p1223
Chris Morrison
doi:10.1038/nbt1215-1223

Advertisement
Renova Life Inc. specializes in transgenic rabbits and guinea pigs production via conventional DNA or RNA microinjection, engaged in developing bioreactor systems and/or novel disease models with TELAN and CRISPR-Cas9 editing technologies.

For more information, please see
http://www.renovalife.com/transgenic_rabbits.php
http://www.renovalife.com/gene%20editing.php

Bioentrepreneur

Top
Building a business

Share and share alike   pp1224 - 1228
Samuel K Sia and Matthew P Owens
doi:10.1038/nbt.3422

Opinion and Comment

Top
Correspondence

Trade-sale exits in different biotech sectors   pp1229 - 1231
Kenneth Fernald and Eric Claassen
doi:10.1038/nbt.3304

Features

Top
Patents

Patenting parthenotes in the US and Europe   pp1232 - 1234
Vincenzo Senatore, Christopher Thomas Scott and Vittorio Sebastiano
doi:10.1038/nbt.3421
The real nature of a parthenote determines its ultimate value.

Recent patents in antibody engineering   p1235
doi:10.1038/nbt.3430

News and Views

Top

Patching up hematopoietic stem cells   pp1236 - 1238
Giorgia Santilli and Adrian J Thrasher
doi:10.1038/nbt.3425
An approach for efficient genome editing in human hematopoietic stem cells could be useful in the treatment of immunological disorders.

See also: Research by Wang et al.

Your gut microbiome, deconstructed   pp1238 - 1240
Dylan Dodd, Carolina Tropini and Justin L Sonnenburg
doi:10.1038/nbt.3431
Use of sophisticated reductionist and whole-system approaches are providing much-needed technologies to unravel the complex melange of microbiome functions.

Cas9 gets a classmate   pp1240 - 1241
Erik J Sontheimer and Scot A Wolfe
doi:10.1038/nbt.3426
Cpf1 is one of a growing number of class II CRISPR-Cas effectors that expand both our understanding of bacterial immunity and our genome-editing toolset.

Research Highlights   p1241
doi:10.1038/nbt.3424

Biotechnology
JOBS of the week
Faculty Positions in Translational Plant Sciences
University of California, Riverside
Postdoctoral Fellows
Icahn School of Medicine at Mount Sinai
Novo Nordisk Foundation Laureate Research Grants
Novo Nordisk Foundation
One PhD Position
Leibniz-Institut für Polymerforschung Dresden e.V. (IPF)


More Science jobs from
Biotechnology
EVENT
ECB2016 - 17th European Congress on Biotechnology
July 3, 2016
Kraków, Poland
More science events from

Computational Biology

Top
Analysis

Affinity regression predicts the recognition code of nucleic acid-binding proteins   pp1242 - 1249
Raphael Pelossof, Irtisha Singh, Julie L Yang, Matthew T Weirauch, Timothy R Hughes et al.
doi:10.1038/nbt.3343
The specificity of DNA- and RNA-binding proteins is predicted from primary protein sequences using a machine learning approach.

Research

Top
Articles

Safeguarding CRISPR-Cas9 gene drives in yeast   pp1250 - 1255
James E DiCarlo, Alejandro Chavez, Sven L Dietz, Kevin M Esvelt and George M Church
doi:10.1038/nbt.3412
Molecular strategies are developed to safeguard the use of CRISPR-Cas9 gene drive technology.

Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors   pp1256 - 1263
Jianbin Wang, Colin M Exline, Joshua J DeClercq, G Nicholas Llewellyn, Samuel B Hayward et al.
doi:10.1038/nbt.3408

See also: News and Views by Santilli & Thrasher

Long-term culture and expansion of primary human hepatocytes   pp1264 - 1271
Gahl Levy, David Bomze, Stefan Heinz, Sarada Devi Ramachandran, Astrid Noerenberg et al.
doi:10.1038/nbt.3377
Primary human hepatocytes are expanded in culture while retaining metabolic function.

Evolution of translation machinery in recoded bacteria enables multi-site incorporation of nonstandard amino acids   pp1272 - 1279
Miriam Amiram, Adrian D Haimovich, Chenguang Fan, Yane-Shih Wang, Hans-Rudolf Aerni et al.
doi:10.1038/nbt.3372
Non-standard amino acids are incorporated into proteins at large numbers of sites using evolved translation components in recoded bacteria.

Letters

Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics   pp1280 - 1286
Sung Il Park, Daniel S Brenner, Gunchul Shin, Clinton D Morgan, Bryan A Copits et al.
doi:10.1038/nbt.3415
Optogenetic studies of the peripheral nervous system and spinal cord are enabled by soft, wirelessly powered biocompatible devices.

GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions   pp1287 - 1292
Judith Agudo, Albert Ruzo, Eun Sook Park, Robert Sweeney, Veronika Kana et al.
doi:10.1038/nbt.3386
T cells specific for GFP allow depletion of specific cell types in mice.

Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition   pp1293 - 1298
Benjamin P Kleinstiver, Michelle S Prew, Shengdar Q Tsai, Nhu T Nguyen, Ved V Topkar et al.
doi:10.1038/nbt.3404
Utility of the small Staphylococcus aureus Cas9 is improved by broadening its targeting range through molecular evolution of its PAM sequence.

Careers and Recruitment

Top
People

People   p1300
doi:10.1038/nbt.3429

Advertisement
This special issue, the last of our 10th anniversary volume, presents a collection of articles focused on "Frontiers in chemical biology" and identifies some of the emerging scientific areas that will engage chemical biologists in the coming years. 

Click here to see this issue! 
 
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments:

Post a Comment